Home » Helen Amata

Helen Amata

Summer Analyst (2020)

Helen Amata was a Summer Analyst at CBPartners.

Connect with Helen Amata


Published Articles

How Do Companies Spend the Revenue Generated from Blockbuster Drugs? A Closer Look at Vertex and Gilead

Blockbuster drugs can generate billions of dollars for pharmaceutical manufacturers, but what can be learned from the investment strategies that GILEAD and VERTEX pursued from the revenue that they generated from SOVALDI and ORKAMBI respectively?